Author:
Chalkias Athanasios,O’Donnell E. Paul
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference47 articles.
1. Shiga T (2022) Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure. Eur Heart J Suppl 24:D11–D21. https://doi.org/10.1093/eurheartjsupp/suac023
2. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M (1992) Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo) 40:1462–1469. https://doi.org/10.1248/cpb.40.1462. PMID: 1356643
3. Nasrollahi-Shirazi S, Sucic S, Yang Q, Freissmuth M, Nanoff C (2016) Comparison of the β-adrenergic receptor antagonists landiolol and esmolol: receptor selectivity, partial agonism, and pharmacochaperoning actions. J Pharmacol Exp Ther 359:73–81. https://doi.org/10.1124/jpet.116.232884
4. Eagle Pharmaceuticals announces submission of New Drug Application to US Food and Drug Administration for landiolol, a beta-1 adrenergic blocker. News release (2003) Eagle Pharmaceuticals, Inc. https://www.globenewswire.com/news-release/2022/06/01/2454027/0/en/Eagle-Pharmaceuticals-Announces-Submission-of-New-Drug-Application-to-U-S-Food-and-Drug-Administration-for-Landiolol-a-Beta-1-Adrenergic-Blocker.html. Accessed 17 May 2023
5. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific Document Group (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373–498. https://doi.org/10.1093/eurheartj/ehaa612